secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ernexa Therapeutics Inc. (ERNA)
CIK:        0000748592
Form:       8-K
Filed at:   2022-01-20T23:59:59+00:00
Accession:  0001140361-22-002104
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Brooklyn ImmunoTherapeutics appoints Heather B. Redman and Erin S. Enright to board
--------------------------------------------------------------------------------

- Board expanded from 5 to 6; Redman and Enright appointed Jan 14, 2022.
- Redman is Managing Partner at Flying Fish Partners; Enright is Managing Member at Prettybrook Partners.
- Each received option for 67,000 shares of common stock under 2020 Plan, vesting over 3 years.
- Redman joins Compensation and Nominating/Governance Committees; Enright chairs Audit Committee.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/748592/000114036122002104/0001140361-22-002104-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/748592/000114036122002104/brhc10032872_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-22-002104

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer